Article - 11/05/2008 New strategy against cervical cancer The German Cancer Research Centre and the Spanish company Chimera Pharma SL have signed an exclusive licensing and cooperation agreement. The two partners will develop a therapeutic vaccine against cervical cancer.https://www.gesundheitsindustrie-bw.de/en/article/news/new-strategy-against-cervical-cancer
Article - 13/04/2008 Selective internal radiotherapy Since early 2008 the Institute of Clinical Radiology and Nuclear Medicine at Mannheim University Hospital has been offering a new therapy for the treatment of liver cancers selective internal radiotherapy SIRT.https://www.gesundheitsindustrie-bw.de/en/article/news/selective-internal-radiotherapy
Article - 10/03/2008 Heinz Schaller receives Löffler Frosch Medal Heinz Schaller of the Centre for Molecular Biology at the University of Heidelberg ZMBH was awarded the Löffler Frosch Medal for his research on viral infections. He was co-founder of the biotechnology company Biogen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heinz-schaller-receives-loeffler-frosch-medal
Article - 01/03/2008 New active substance against hepatitis B Scientists at the University Hospital in Heidelberg have discovered a hepatitis B virus peptide that can prevent viral infections in a mouse model. A team led by Professor Stephan Urban is developing a virus blocker against hepatitis B infections. Despite vaccinations every year about 750000 people die from the consequences of hepatitis B infections.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-active-substance-against-hepatitis-b